Ambler, PA, United States of America

James T Walter

This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Mcneil-Ppc, Inc.. Active years: 2000-2010.

USPTO Granted Patents = 6 

% Patents Active = 83.3


Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 98(Granted Patents)


Company Filing History:


Years Active: 2000-2010

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: James T Walter: Innovator in Pharmaceutical Formulations

Introduction

James T Walter is a notable inventor based in Ambler, PA (US), recognized for his contributions to pharmaceutical formulations. He holds a total of 6 patents, showcasing his innovative approach to creating effective medical solutions.

Latest Patents

One of his latest patents is focused on a simethicone solid oral dosage form. This invention provides a composition for forming a compressed solid dosage form that is a free-flowing compressible admixture of simethicone, an adsorbent, and an optional active agent. The weight ratio of simethicone to adsorbent is at least 1:2.22. This patent emphasizes the importance of the specific weight ratio in achieving the desired properties of the dosage form.

Career Highlights

Throughout his career, James T Walter has worked with prominent companies such as McNeil-PPC, Inc. and McNeil-PCC, Inc. His experience in these organizations has contributed significantly to his expertise in pharmaceutical innovations.

Collaborations

James has collaborated with notable colleagues, including Sunanda R Kulkarni and Robert T McFadden. These partnerships have likely enriched his work and led to further advancements in his field.

Conclusion

James T Walter's innovative contributions to pharmaceutical formulations, particularly in simethicone solid oral dosage forms, highlight his role as a significant inventor in the industry. His work continues to impact the field of medicine positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…